Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells

Zahra Kabiri, Akihiko Numata, Akira Kawasaki, Edison, Daniel G. Tenen, David M. Virshup

Blood · 2015 · 66 citations · 56 references

DOIFull text

Open access

Concepts

Abstract

Wnt secretion can be genetically and pharmacologically blocked without effect on normal adult hematopoiesis. The clinical use of upstream Wnt inhibitors is unlikely to cause significant hematopoietic toxicity. Wnt signaling controls early embryonic hematopoiesis and dysregulated b-catenin is implicated in leukemia. However, the role of Wnts and their source in adult hematopoiesis is still unclear, and is clinically important as upstream Wnt inhibitors enter clinical trials. We blocked Wnt secretion in hematopoietic lineages by targeting Porcn, a membrane-bound O-acyltransferase that is indispensable for the activity and secretion of all vertebrate Wnts. Surprisingly, deletion of Porcn in Rosa-CreER T2 /Porcn Del , MX1-Cre/Porcn Del , and Vav-Cre/Porcn Del mice had no effects on proliferation, differentiation, or self-renewal of adult hematopoietic stem cells. Targeting Wnt secretion in the bone marrow niche by treatment with a PORCN inhibitor, C59, similarly had no effect on hematopoiesis. These results exclude a role for hematopoietic PORCNdependent Wnts in adult hematopoiesis. Clinical use of upstream Wnt inhibitors is not likely to be limited by effects on hematopoiesis. (Blood.

References

56